Elanco Animal Health (ELAN) - Stock & Dividends

Elanco Animal Health, listed on the New York Stock Exchange under the ticker ELAN, is a leading animal health company that focuses on creating, manufacturing, and distributing innovative products for both household pets and farm animals.

Their extensive product range includes pet health disease prevention items like parasiticides and vaccines, safeguarding pets from common issues like worms, fleas, and ticks. Brands such as Seresto, Advantage, Advantix, and Advocate offer effective protection for pets.

In addition to this, Elanco provides pet health therapeutics to address various health concerns in dogs and cats, such as pain management, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems. Their products under brands like Galliprant and Claro are designed to improve the well-being of pets.

Furthermore, Elanco's offerings extend to poultry and aquaculture sectors, providing vaccines, antibiotics, parasiticides, and nutritional health products such as enzymes, probiotics, and prebiotics. They also cater to ruminant and swine production with a wide range of vaccines, antibiotics, implants, and parasiticides under the Rumensin and Baytril brands.

The company serves a broad customer base, selling products to third-party distributors, veterinarians, and various farm animal producers, including beef and dairy farmers, pork, poultry, and aquaculture operations.

Established in 1954, Elanco Animal Health is headquartered in Greenfield, Indiana. To learn more about their products and mission, visit their website at https://www.elanco.com.